Gut microbiota–Arachidonic acid axis mediates T2DM-associated erectile dysfunction after FMT

Gut microbiota dysbiosis transfers ED phenotype via FMT

This study used fecal microbiota transplantation (FMT) to test whether gut microbial imbalance contributes causally to type 2 diabetes mellitus–associated erectile dysfunction (T2DM-ED). FMT from T2DM-ED donor rats into pseudo–germ-free recipient rats reproduced the erectile impairment seen in donors, with recipients showing significantly reduced intracavernosal pressure to mean arterial pressure (ICP/MAP) ratios. The results indicate that gut microbiota alterations are sufficient to transfer an ED phenotype in this experimental model.

Colonic barrier disruption and tight junction changes after ED-FMT

Recipients of ED-derived microbiota exhibited multiple signs of intestinal barrier injury. Observations included impaired colonic barrier integrity, mucosal damage, depletion of goblet cells, and downregulation of tight junction proteins such as Occludin and Claudin-4. These findings link transplanted dysbiotic communities to compromised gut barrier function, which may enable systemic transmission of microbial metabolites or inflammatory mediators.

Multi-omics identification of arachidonic acid as a key serum metabolite

The investigators combined 16S rRNA gene sequencing of gut microbiota with serum metabolomics to identify candidate mediators bridging gut changes and penile pathology. Integration of these data highlighted arachidonic acid (AA) as a prominent elevated serum metabolite associated with the ED phenotype. AA was implicated in driving downstream inflammatory signaling, particularly through HIF-1α and NF-κB pathways according to the multi-omics associations reported.

Penile tissue pathology and activation of TLR4-MyD88-NF-κB-HIF-1α axis

Histological and molecular analyses of penile corpus cavernosum tissue from ED-FMT rats revealed pathologic alterations consistent with T2DM-ED. Key tissue-level changes included loss of smooth muscle, increased fibrosis, and elevated apoptosis. At the signaling level, the penile tissue from ED-FMT recipients showed hyperactivation of the TLR4-MyD88-NF-κB-HIF-1α axis. These findings provide a mechanistic link between systemic inflammatory signaling and local structural and cellular damage in the corpus cavernosum.

AA effects in primary corpus cavernosum smooth muscle cells and NF-κB dependence

To test causality of the metabolite, primary corpus cavernosum smooth muscle cells (CCSMCs) were exposed to AA in vitro. AA stimulation recapitulated many pathological molecular signatures: a shift toward a pro-apoptotic Bax/Bcl-2 ratio, increased Cleaved Caspase-3, reduced α-smooth muscle actin (α-SMA), elevated COX-2 expression, stabilization of HIF-1α, and excessive prostaglandin E2 (PGE2) production. Importantly, pharmacologic inhibition of NF-κB abolished these AA-induced changes in CCSMCs, indicating that AA acts via NF-κB–dependent inflammatory signaling to produce cellular injury in penile smooth muscle.

Proposed gut–AA–NF-κB–penis mechanistic axis and therapeutic implications

Bringing these strands together, the authors propose a mechanistic gut–AA–NF-κB–penis axis in which gut dysbiosis leads to systemic accumulation of arachidonic acid, which then activates TLR4-MyD88–dependent and NF-κB/HIF-1α inflammatory signaling in penile tissue. This cascade promotes inflammation, apoptosis, smooth muscle loss, fibrosis, and ultimately erectile dysfunction in the T2DM setting. The study positions AA and its downstream signaling components, particularly NF-κB and HIF-1α pathways, as potential therapeutic targets for diabetic erectile dysfunction.

Study scope and source-derived limits

All findings summarized here derive from the reported animal experiments and multi-omics analyses described in the source abstract. Specific experimental details (for example, sample sizes, statistical values, exact FMT procedures, duration of follow-up, or full metabolomic lists) were not provided in the abstract and therefore are not recapitulated. The translational relevance to human T2DM-ED patients was not evaluated in the abstract and would require further clinical investigation.

Key clinical and research takeaways

• Gut microbiota dysbiosis can transfer an ED phenotype in rats via FMT, supporting a causal role for the microbiome in T2DM-ED.
• Arachidonic acid emerges as a key circulating metabolite linking gut changes to penile pathology.
• The TLR4-MyD88–NF-κB–HIF-1α signaling cascade mediates inflammatory and apoptotic responses in corpus cavernosum smooth muscle, driving structural and functional impairment.
• NF-κB inhibition prevented AA-driven molecular damage in primary CCSMCs, suggesting a potential intervention point.
• The authors propose targeting AA metabolism or downstream inflammatory signaling as candidate therapeutic strategies for diabetic erectile dysfunction, while recognizing that the abstract does not include human data or full methodological detail.